A gene therapy that has allowed several children born deaf to hear for the first time is being hailed as a “game changer” that raises hopes of the first new treatment for hereditary deafness in decades.
Several medical teams around the world are trialling the procedure, which focuses on a rare genetic mutation that affects only a small number of the 26 million people with congenital deafness globally.
However, several success stories announced last week are being seen as a turning point.
Photo: Children’s Hospital of Philadelphia via AP
On Tuesday last week, the Children’s Hospital of Philadelphia in Pennsylvania revealed that 11-year-old Aissam Dam, who was born deaf, was now “literally hearing sound for the first time in his life.”
Aissam still has mild-to-moderate hearing loss and might never learn to talk because the brain’s window for acquiring speech closes around the age of five.
However, a trial in China, the results of which were announced in The Lancet journal on Thursday, tested a similar treatment on six younger children.
Five gained the ability to hear, according to the findings of the trial that started in 2022, making it the first to have tested the gene therapy on humans.
Some of the children were already able to speak thanks to a cochlear implant — which they now no longer need, study coauthor Zheng-yi Chen of the Massachusetts Eye and Ear hospital said.
However, one, a baby only a year old, had never been able to communicate verbally, Chen said.
Chen said that after the treatment, when the mother asked the baby “Who am I?” the baby responded: “Mama.”
When asked what a chicken sounds like, the baby responded: “Coo-coo.”
“Everyone just cried with joy, it’s really amazing,” Chen said, adding that the baby was expected to grow up speaking normally.
Not since cochlear implants were invented 60 years has there been such an advance, Chen said, adding that the therapy “symbolizes a new era in the fight against all types of hearing loss.”
For now, the trials in China, the US and another announced in France this week all use a similar technique to focus on people born with a mutation of the OTOF gene.
This defect means they can no longer produce the protein otoferlin, which is needed for hair cells in the inner ear to convert sound vibrations into electrical signals that can be sent to the brain.
The treatment involves injecting a harmless virus into the inner ear that smuggles in a working version of the OTOF gene, restoring hearing.
The French trial is to focus on babies aged 12 months to 31 months, in the hopes it can “enable the acquisition of language”, said Nawal Ouzren, CEO of the firm Sensorion developing the treatment.
Natalie Loundon, a French doctor and hearing loss expert, called the technique “a game changer, a technological advance that will revolutionize therapeutic care.”
“The idea is to be able to offer this treatment to children rather than an implant, which is not always received well,” she said.
For the China-based trial, the researchers are to continue to study the participants to find out if their improved hearing lasts.
Chen estimated that the treatment tested in that trial could be ready to apply for regulatory approval within three to five years.
However, this particular treatment could only help a fraction of those born deaf.
About one in every 1,000 children are born deaf due to gene defects, but a lack of otoferlin is the cause of only about three percent of those cases.
More than 150 other genes have been discovered that trigger genetic hearing loss.
However, Chen had some good news.
So far, the otoferlin treatment seems to work just as well in humans as it did in during trials on mice — which is not always the case for such research.
Trials on mice targeting other gene defects that cause hearing loss have also been successful, Chen said.
Researchers therefore hope this first treatment opens the door to others.
Pasteur Institute in Paris, which pioneered the research on otoferlin, and Sensorion are already working on another therapy that focuses on a gene whose mutations are responsible for the most common forms of hereditary deafness.
The Philippines yesterday said its coast guard would acquire 40 fast patrol craft from France, with plans to deploy some of them in disputed areas of the South China Sea. The deal is the “largest so far single purchase” in Manila’s ongoing effort to modernize its coast guard, with deliveries set to start in four years, Philippine Coast Guard Commandant Admiral Ronnie Gil Gavan told a news conference. He declined to provide specifications for the vessels, which Manila said would cost 25.8 billion pesos (US$440 million), to be funded by development aid from the French government. He said some of the vessels would
CARGO PLANE VECTOR: Officials said they believe that attacks involving incendiary devices on planes was the work of Russia’s military intelligence agency the GRU Western security officials suspect Russian intelligence was behind a plot to put incendiary devices in packages on cargo planes headed to North America, including one that caught fire at a courier hub in Germany and another that ignited in a warehouse in England. Poland last month said that it had arrested four people suspected to be linked to a foreign intelligence operation that carried out sabotage and was searching for two others. Lithuania’s prosecutor general Nida Grunskiene on Tuesday said that there were an unspecified number of people detained in several countries, offering no elaboration. The events come as Western officials say
A plane bringing Israeli soccer supporters home from Amsterdam landed at Israel’s Ben Gurion airport on Friday after a night of violence that Israeli and Dutch officials condemned as “anti-Semitic.” Dutch police said 62 arrests were made in connection with the violence, which erupted after a UEFA Europa League soccer tie between Amsterdam club Ajax and Maccabi Tel Aviv. Israeli flag carrier El Al said it was sending six planes to the Netherlands to bring the fans home, after the first flight carrying evacuees landed on Friday afternoon, the Israeli Airports Authority said. Israeli Prime Minister Benjamin Netanyahu also ordered
Former US House of Representatives speaker Nancy Pelosi said if US President Joe Biden had ended his re-election bid sooner, the Democratic Party could have held a competitive nominating process to choose his replacement. “Had the president gotten out sooner, there may have been other candidates in the race,” Pelosi said in an interview on Thursday published by the New York Times the next day. “The anticipation was that, if the president were to step aside, that there would be an open primary,” she said. Pelosi said she thought the Democratic candidate, US Vice President Kamala Harris, “would have done
RSS